Global and United States Molecular Diagnosis of Clostridium Difficile Market Report & Forecast 2022-2028

Table of Contents

1 Study Coverage

• 1.1 Molecular Diagnosis of Clostridium Difficile Product Introduction
• 1.2 Global Molecular Diagnosis of Clostridium Difficile Outlook 2017 VS 2022 VS 2028
  • 1.2.1 Global Molecular Diagnosis of Clostridium Difficile Sales in US$ Million for the Year 2017-2028
  • 1.2.2 Global Molecular Diagnosis of Clostridium Difficile Sales in Volume for the Year 2017-2028
• 1.3 United States Molecular Diagnosis of Clostridium Difficile Outlook 2017 VS 2022 VS 2028
  • 1.3.1 United States Molecular Diagnosis of Clostridium Difficile Sales in US$ Million for the Year 2017-2028
  • 1.3.2 United States Molecular Diagnosis of Clostridium Difficile Sales in Volume for the Year 2017-2028
• 1.4 Molecular Diagnosis of Clostridium Difficile Market Size, United States VS Global, 2017 VS 2022 VS 2028
  • 1.4.1 The Market Share of United States Molecular Diagnosis of Clostridium Difficile in Global, 2017 VS 2022 VS 2028
  • 1.4.2 The Growth Rate of Molecular Diagnosis of Clostridium Difficile Market Size, United States VS Global, 2017 VS 2022 VS 2028
• 1.5 Molecular Diagnosis of Clostridium Difficile Market Dynamics
  • 1.5.1 Molecular Diagnosis of Clostridium Difficile Industry Trends
  • 1.5.2 Molecular Diagnosis of Clostridium Difficile Market Drivers
  • 1.5.3 Molecular Diagnosis of Clostridium Difficile Market Challenges
  • 1.5.4 Molecular Diagnosis of Clostridium Difficile Market Restraints
• 1.6 Study Objectives
• 1.7 Years Considered

2 Market by Type

• 2.1 Molecular Diagnosis of Clostridium Difficile Market Segment by Type
  • 2.1.1 Sensitivity Above 90%
  • 2.1.2 Sensitivity Below 90%
• 2.2 Global Molecular Diagnosis of Clostridium Difficile Market Size by Type
  • 2.2.1 Global Molecular Diagnosis of Clostridium Difficile Sales in Value, by Type (2017, 2022 & 2028)
  • 2.2.2 Global Molecular Diagnosis of Clostridium Difficile Sales in Volume, by Type (2017, 2022 & 2028)
  • 2.2.3 Global Molecular Diagnosis of Clostridium Difficile Average Selling Price (ASP) by Type (2017, 2022 & 2028)
• 2.3 United States Molecular Diagnosis of Clostridium Difficile Market Size by Type
  • 2.3.1 United States Molecular Diagnosis of Clostridium Difficile Sales in Value, by Type (2017, 2022 & 2028)
  • 2.3.2 United States Molecular Diagnosis of Clostridium Difficile Sales in Volume, by Type (2017, 2022 & 2028)
  • 2.3.3 United States Molecular Diagnosis of Clostridium Difficile Average Selling Price (ASP) by Type (2017, 2022 & 2028)

3 Market by Application

• 3.1 Molecular Diagnosis of Clostridium Difficile Market Segment by Application
  • 3.1.1 Hospital
  • 3.1.2 Clinic
  • 3.1.3 Laboratory
  • 3.1.4 Home Care
  • 3.1.5 Others
• 3.2 Global Molecular Diagnosis of Clostridium Difficile Market Size by Application
  • 3.2.1 Global Molecular Diagnosis of Clostridium Difficile Sales in Value, by Application (2017, 2022 & 2028)
  • 3.2.2 Global Molecular Diagnosis of Clostridium Difficile Sales in Volume, by Application (2017, 2022 & 2028)
  • 3.3.3 Global Molecular Diagnosis of Clostridium Difficile Average Selling Price (ASP) by Application (2017, 2022 & 2028)
• 3.3 United States Molecular Diagnosis of Clostridium Difficile Market Size by Application
  • 3.3.1 United States Molecular Diagnosis of Clostridium Difficile Sales in Value, by Application (2017, 2022 & 2028)
  • 3.3.2 United States Molecular Diagnosis of Clostridium Difficile Sales in Volume, by Application (2017, 2022 & 2028)
  • 3.3.3 United States Molecular Diagnosis of Clostridium Difficile Average Selling Price (ASP) by Application (2017, 2022 & 2028)

4 Global Molecular Diagnosis of Clostridium Difficile Competitor Landscape by Company

• 4.1 Global Molecular Diagnosis of Clostridium Difficile Market Size by Company
  • 4.1.1 Top Global Molecular Diagnosis of Clostridium Difficile Manufacturers Ranked by Revenue (2021)
  • 4.1.2 Global Molecular Diagnosis of Clostridium Difficile Revenue by Manufacturer (2017-2022)
  • 4.1.3 Global Molecular Diagnosis of Clostridium Difficile Sales by Manufacturer (2017-2022)
  • 4.1.4 Global Molecular Diagnosis of Clostridium Difficile Price by Manufacturer (2017-2022)
• 4.2 Global Molecular Diagnosis of Clostridium Difficile Concentration Ratio (CR)
  • 4.2.1 Molecular Diagnosis of Clostridium Difficile Market Concentration Ratio (CR) (2017-2022)
  • 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Molecular Diagnosis of Clostridium Difficile in 2021
  • 4.2.3 Global Molecular Diagnosis of Clostridium Difficile Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 4.3 Global Molecular Diagnosis of Clostridium Difficile Manufacturing Base Distribution, Product Type
  • 4.3.1 Global Molecular Diagnosis of Clostridium Difficile Manufacturers, Headquarters and Distribution of Producing Region
  • 4.3.2 Manufacturers Molecular Diagnosis of Clostridium Difficile Product Type
  • 4.3.3 Date of International Manufacturers Enter into Molecular Diagnosis of Clostridium Difficile Market
• 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
• 4.5 United States Molecular Diagnosis of Clostridium Difficile Market Size by Company
  • 4.5.1 Top Molecular Diagnosis of Clostridium Difficile Players in United States, Ranked by Revenue (2021)
  • 4.5.2 United States Molecular Diagnosis of Clostridium Difficile Revenue by Players (2020, 2021 & 2022)
  • 4.5.3 United States Molecular Diagnosis of Clostridium Difficile Sales by Players (2020, 2021 & 2022)

5 Global Molecular Diagnosis of Clostridium Difficile Market Size by Region

• 5.1 Global Molecular Diagnosis of Clostridium Difficile Market Size by Region: 2017 VS 2022 VS 2028
• 5.2 Global Molecular Diagnosis of Clostridium Difficile Market Size in Volume by Region (2017-2028)
  • 5.2.1 Global Molecular Diagnosis of Clostridium Difficile Sales in Volume by Region: 2017-2022
  • 5.2.2 Global Molecular Diagnosis of Clostridium Difficile Sales in Volume Forecast by Region (2023-2028)
• 5.3 Global Molecular Diagnosis of Clostridium Difficile Market Size in Value by Region (2017-2028)
  • 5.3.1 Global Molecular Diagnosis of Clostridium Difficile Sales in Value by Region: 2017-2022
  • 5.3.2 Global Molecular Diagnosis of Clostridium Difficile Sales in Value by Region: 2023-2028

6 Segment in Region Level & Country Level

• 6.1 North America
  • 6.1.1 North America Molecular Diagnosis of Clostridium Difficile Market Size YoY Growth 2017-2028
  • 6.1.2 North America Molecular Diagnosis of Clostridium Difficile Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.1.3 United States
  • 6.1.4 Canada
• 6.2 Asia-Pacific
  • 6.2.1 Asia-Pacific Molecular Diagnosis of Clostridium Difficile Market Size YoY Growth 2017-2028
  • 6.2.2 Asia-Pacific Molecular Diagnosis of Clostridium Difficile Market Facts & Figures by Region (2017, 2022 & 2028)
  • 6.2.3 China
  • 6.2.4 Japan
  • 6.2.5 South Korea
  • 6.2.6 India
  • 6.2.7 Australia
  • 6.2.8 China Taiwan
  • 6.2.9 Indonesia
  • 6.2.10 Thailand
  • 6.2.11 Malaysia
• 6.3 Europe
  • 6.3.1 Europe Molecular Diagnosis of Clostridium Difficile Market Size YoY Growth 2017-2028
  • 6.3.2 Europe Molecular Diagnosis of Clostridium Difficile Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.3.3 Germany
  • 6.3.4 France
  • 6.3.5 U.K.
  • 6.3.6 Italy
  • 6.3.7 Russia
• 6.4 Latin America
  • 6.4.1 Latin America Molecular Diagnosis of Clostridium Difficile Market Size YoY Growth 2017-2028
  • 6.4.2 Latin America Molecular Diagnosis of Clostridium Difficile Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.4.3 Mexico
  • 6.4.4 Brazil
  • 6.4.5 Argentina
• 6.5 Middle East and Africa
  • 6.5.1 Middle East and Africa Molecular Diagnosis of Clostridium Difficile Market Size YoY Growth 2017-2028
  • 6.5.2 Middle East and Africa Molecular Diagnosis of Clostridium Difficile Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.5.3 Turkey
  • 6.5.4 Saudi Arabia
  • 6.5.5 UAE

7 Company Profiles

• 7.1 Roche
  • 7.1.1 Roche Corporation Information
  • 7.1.2 Roche Description and Business Overview
  • 7.1.3 Roche Molecular Diagnosis of Clostridium Difficile Sales, Revenue and Gross Margin (2017-2022)
  • 7.1.4 Roche Molecular Diagnosis of Clostridium Difficile Products Offered
  • 7.1.5 Roche Recent Development
• 7.2 Thermo Scientific
  • 7.2.1 Thermo Scientific Corporation Information
  • 7.2.2 Thermo Scientific Description and Business Overview
  • 7.2.3 Thermo Scientific Molecular Diagnosis of Clostridium Difficile Sales, Revenue and Gross Margin (2017-2022)
  • 7.2.4 Thermo Scientific Molecular Diagnosis of Clostridium Difficile Products Offered
  • 7.2.5 Thermo Scientific Recent Development
• 7.3 Cepheid (Danaher)
  • 7.3.1 Cepheid (Danaher) Corporation Information
  • 7.3.2 Cepheid (Danaher) Description and Business Overview
  • 7.3.3 Cepheid (Danaher) Molecular Diagnosis of Clostridium Difficile Sales, Revenue and Gross Margin (2017-2022)
  • 7.3.4 Cepheid (Danaher) Molecular Diagnosis of Clostridium Difficile Products Offered
  • 7.3.5 Cepheid (Danaher) Recent Development
• 7.4 BD
  • 7.4.1 BD Corporation Information
  • 7.4.2 BD Description and Business Overview
  • 7.4.3 BD Molecular Diagnosis of Clostridium Difficile Sales, Revenue and Gross Margin (2017-2022)
  • 7.4.4 BD Molecular Diagnosis of Clostridium Difficile Products Offered
  • 7.4.5 BD Recent Development
• 7.5 Meridian
  • 7.5.1 Meridian Corporation Information
  • 7.5.2 Meridian Description and Business Overview
  • 7.5.3 Meridian Molecular Diagnosis of Clostridium Difficile Sales, Revenue and Gross Margin (2017-2022)
  • 7.5.4 Meridian Molecular Diagnosis of Clostridium Difficile Products Offered
  • 7.5.5 Meridian Recent Development
• 7.6 TECHLAB
  • 7.6.1 TECHLAB Corporation Information
  • 7.6.2 TECHLAB Description and Business Overview
  • 7.6.3 TECHLAB Molecular Diagnosis of Clostridium Difficile Sales, Revenue and Gross Margin (2017-2022)
  • 7.6.4 TECHLAB Molecular Diagnosis of Clostridium Difficile Products Offered
  • 7.6.5 TECHLAB Recent Development
• 7.7 Luminex
  • 7.7.1 Luminex Corporation Information
  • 7.7.2 Luminex Description and Business Overview
  • 7.7.3 Luminex Molecular Diagnosis of Clostridium Difficile Sales, Revenue and Gross Margin (2017-2022)
  • 7.7.4 Luminex Molecular Diagnosis of Clostridium Difficile Products Offered
  • 7.7.5 Luminex Recent Development
• 7.8 CerTest Biotec
  • 7.8.1 CerTest Biotec Corporation Information
  • 7.8.2 CerTest Biotec Description and Business Overview
  • 7.8.3 CerTest Biotec Molecular Diagnosis of Clostridium Difficile Sales, Revenue and Gross Margin (2017-2022)
  • 7.8.4 CerTest Biotec Molecular Diagnosis of Clostridium Difficile Products Offered
  • 7.8.5 CerTest Biotec Recent Development
• 7.9 Quidel
  • 7.9.1 Quidel Corporation Information
  • 7.9.2 Quidel Description and Business Overview
  • 7.9.3 Quidel Molecular Diagnosis of Clostridium Difficile Sales, Revenue and Gross Margin (2017-2022)
  • 7.9.4 Quidel Molecular Diagnosis of Clostridium Difficile Products Offered
  • 7.9.5 Quidel Recent Development
• 7.10 Zhejiang Orient Gene Biotech
  • 7.10.1 Zhejiang Orient Gene Biotech Corporation Information
  • 7.10.2 Zhejiang Orient Gene Biotech Description and Business Overview
  • 7.10.3 Zhejiang Orient Gene Biotech Molecular Diagnosis of Clostridium Difficile Sales, Revenue and Gross Margin (2017-2022)
  • 7.10.4 Zhejiang Orient Gene Biotech Molecular Diagnosis of Clostridium Difficile Products Offered
  • 7.10.5 Zhejiang Orient Gene Biotech Recent Development
• 7.11 Beijing Promed Medical Technology
  • 7.11.1 Beijing Promed Medical Technology Corporation Information
  • 7.11.2 Beijing Promed Medical Technology Description and Business Overview
  • 7.11.3 Beijing Promed Medical Technology Molecular Diagnosis of Clostridium Difficile Sales, Revenue and Gross Margin (2017-2022)
  • 7.11.4 Beijing Promed Medical Technology Molecular Diagnosis of Clostridium Difficile Products Offered
  • 7.11.5 Beijing Promed Medical Technology Recent Development
• 7.12 Jiangsu Besthree Biotechnology
  • 7.12.1 Jiangsu Besthree Biotechnology Corporation Information
  • 7.12.2 Jiangsu Besthree Biotechnology Description and Business Overview
  • 7.12.3 Jiangsu Besthree Biotechnology Molecular Diagnosis of Clostridium Difficile Sales, Revenue and Gross Margin (2017-2022)
  • 7.12.4 Jiangsu Besthree Biotechnology Products Offered
  • 7.12.5 Jiangsu Besthree Biotechnology Recent Development

8 Industry Chain and Sales Channels Analysis

• 8.1 Molecular Diagnosis of Clostridium Difficile Industry Chain Analysis
• 8.2 Molecular Diagnosis of Clostridium Difficile Key Raw Materials
  • 8.2.1 Key Raw Materials
  • 8.2.2 Molecular Diagnosis of Clostridium Difficile Distributors
• 8.3 Molecular Diagnosis of Clostridium Difficile Production Mode & Process
• 8.4 Molecular Diagnosis of Clostridium Difficile Sales and Marketing
  • 8.4.1 Molecular Diagnosis of Clostridium Difficile Sales Channels
  • 8.4.2 Molecular Diagnosis of Clostridium Difficile Distributors
• 8.5 Molecular Diagnosis of Clostridium Difficile Customers

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
  • 10.1.2 Data Source
• 10.2 Author Details